NCT04436315 is a NA clinical trial of Motor-cognitive training device in Exergame, sponsored by Davy Vancampfort.

Who is sponsoring NCT04436315?

NCT04436315 is sponsored by Davy Vancampfort.

What drugs are being tested in NCT04436315?

Interventions in NCT04436315: Motor-cognitive training device, Active control condition.

What condition does NCT04436315 study?

NCT04436315 studies Exergame, Major Neurocognitive Disorder, Long-term Care Facility, Nursing Home.

Is NCT04436315 still recruiting?

NCT04436315 is currently status unknown. Last updated 24 August 2021.

Last reviewed 2021-08-24 · How we verify

NCT04436315

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Intervention Study of an Individualized Exergame Training for People With Major Neurocognitive Disorder

Status unknown NA Last updated 24 August 2021

What this trial tests

NA trial testing Motor-cognitive training device in Exergame in 60 participants. Status unknown.

Timeline

1 April 2021

Primary endpoint
30 December 2021

30 December 2021

Quick facts

Lead sponsor	Davy Vancampfort
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	treatment
Enrollment	60
Start date	1 April 2021
Primary completion	30 December 2021
Estimated completion	30 December 2021
Sites	1 location across Belgium

Drugs / interventions tested

Motor-cognitive training device
Active control condition

Conditions studied

Exergame — all drugs for Exergame →
Major Neurocognitive Disorder — all drugs for Major Neurocognitive Disorder →
Long-term Care Facility — all drugs for Long-term Care Facility →
Nursing Home — all drugs for Nursing Home →

Sponsor

Davy Vancampfort

Who can join

60 and older, any sex, with Exergame or Major Neurocognitive Disorder. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study evaluates the feasibility of the intervention and the study design.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

The feasibility of a stepping exergame prototype for older adults with major neurocognitive disorder residing in a long-term care facility: a mixed methods pilot study.
Swinnen N, de Bruin ED, Guimarães V, Dumoulin C, et al · · 2023 · cited 11× · PMID 36824039 · DOI 10.1080/09638288.2023.2182916

Verify or expand the search:

Other recruiting trials for Exergame

Currently open trials in the same condition.

NCT06807892 — Comparison of Two Cognitive-Motor Rehabilitation Approaches Via Exergames: a Study of Cognitive, Motor and Behavioral Fu · NA · recruiting

Other Davy Vancampfort trials

Trials by the same sponsor.

NCT04664920 — An Individualized Exergame Training Solution for People With Major Neurocognitive Disorder: a Usability Study · completed
NCT04436302 — Exergaming in People With Major Neurocognitive Disorder · NA · unknown

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04436315 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Davy Vancampfort
Last refreshed: 24 August 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04436315.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing